Which of the following effects on the coagulation cascade is most likely to result from inhibiting thrombin activity with argatroban?

Effect of Thrombin Inhibitors on Positive Feedback in the Coagulation Cascade

N B Ustinov et al. Biochemistry (Mosc). 2016 Mar.

Abstract

The coagulation cascade is a series of sequential reactions of limited proteolysis of protein factors resulting in generation of thrombin. Thrombin mediates both positive and negative feedback in regulating this cascade by taking part in activation of several factors. Some thrombin inhibitors, by affecting positive feedback, inhibit generation of thrombin itself. In the current study, we used two thrombin inhibitors: argatroban, a low molecular weight reversible competitive inhibitor that binds to the active site, and bivalirudin, a bivalent oligopeptide that blocks the active site and binding center of protein substrates (exosite I). Appearance rate and total amount of thrombin were measured in a thrombin generation assay (TGA) using a fluorescent substrate. We found that argatroban slows the appearance of thrombin and lowers its amount. Bivalirudin also slows appearance of thrombin, but it does not decrease its amount, perhaps because the region being bound to the active site undergoes hydrolysis so that the inhibitor stops binding to thrombin. Many reactions of the coagulation cascade proceed on the surface of phospholipid micelles (PLMs). In the case of argatroban, PLMs do not affect the results of the TGA, whereas for bivalirudin they lower its inhibitory activity. It seems that PLMs stabilize protein complexes (wherein thrombin exosite I is hindered) mediating positive feedback in the coagulation cascade, e.g. complexes of thrombin with factor V and VIII.

Similar articles

  • G-Quadruplex Aptamers to Human Thrombin Versus Other Direct Thrombin Inhibitors: The Focus on Mechanism of Action and Drug Efficiency as Anticoagulants.

    Zavyalova E, Ustinov N, Golovin A, Pavlova G, Kopylov A. Zavyalova E, et al. Curr Med Chem. 2016;23(21):2230-44. doi: 10.2174/0929867323666160517120126. Curr Med Chem. 2016. PMID: 27183984 Review.

  • The ability of thrombin inhibitors to reduce the thrombin activity generated in plasma on extrinsic and intrinsic activation.

    Prasa D, Svendsen L, Stürzebecher J. Prasa D, et al. Thromb Haemost. 1997 Mar;77(3):498-503. Thromb Haemost. 1997. PMID: 9066001

  • Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays.

    Wakui M, Fujimori Y, Nakamura S, Kondo Y, Kuroda Y, Oka S, Nakagawa T, Katagiri H, Murata M. Wakui M, et al. J Clin Pathol. 2019 Dec;72(12):817-824. doi: 10.1136/jclinpath-2019-205922. Epub 2019 Jul 31. J Clin Pathol. 2019. PMID: 31366633

  • Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.

    Cheng Y, Slon-Usakiewicz JJ, Wang J, Purisima EO, Konishi Y. Cheng Y, et al. Biochemistry. 1996 Oct 8;35(40):13021-9. doi: 10.1021/bi961039c. Biochemistry. 1996. PMID: 8855937

  • Inhibitor binding to thrombin: x-ray crystallographic studies.

    Banner DW, Hadváry P. Banner DW, et al. Adv Exp Med Biol. 1993;340:27-33. doi: 10.1007/978-1-4899-2418-6_3. Adv Exp Med Biol. 1993. PMID: 8154341 Review. No abstract available.

Cited by

  • Factor VII Gene Defects: Review of Functional Studies and Their Clinical Implications.

    Shahbazi S, Mahdian R. Shahbazi S, et al. Iran Biomed J. 2019 May;23(3):165-74. doi: 10.29252/.23.3.165. Epub 2019 Feb 24. Iran Biomed J. 2019. PMID: 30797223 Free PMC article. Review.

  • The Evaluation of Pharmacodynamics and Pharmacokinetics of Anti-thrombin DNA Aptamer RA-36.

    Zavyalova E, Samoylenkova N, Revishchin A, Turashev A, Gordeychuk I, Golovin A, Kopylov A, Pavlova G. Zavyalova E, et al. Front Pharmacol. 2017 Dec 14;8:922. doi: 10.3389/fphar.2017.00922. eCollection 2017. Front Pharmacol. 2017. PMID: 29311929 Free PMC article.

  • Effect of Hemodilution In Vitro with Hydroxyethyl Starch on Hemostasis.

    Jin S, Yu G, Hou R, Shen B, Jiang H. Jin S, et al. Med Sci Monit. 2017 May 8;23:2189-2197. doi: 10.12659/msm.901588. Med Sci Monit. 2017. PMID: 28481865 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

  • Full Text Sources

    • Biochemistry (Moscow)
  • Other Literature Sources

    • scite Smart Citations

Which of the following best predicts the effect of inhibiting cyclic AMP phosphodiesterase in a muscle cell stimulated by epinephrine?

Which of the following best predicts the effect of inhibiting cyclic AMP phosphodiesterase in a muscle cell stimulated by epinephrine? Phosphorylase kinase will remain active because protein kinase A will no longer be deactivated.

Which of the following is the most likely effect on calcium homeostasis?

If a dietary change results in an increase in blood calcium concentration above normal levels, which of the following is the most likely effect on calcium homeostasis? Calcitonin levels will rise, thus promoting the deposit of calcium into bones.

Which of the following outcomes will most likely result from the irreversible binding of?

Which of the following outcomes will most likely result from the irreversible binding of GDP to the G protein? The intracellular concentration of glycogen will increase. A researcher claims that the epinephrine signaling pathway controls a catabolic process in muscle cells.

Which of the following best describes how the amount of DNA in the cell changes during M phase?

Which of the following best describes how the amount of DNA in the cell changes during M phase? The amount of DNA is halved as the cell divides into two daughter cells.

Toplist

Neuester Beitrag

Stichworte